131 related articles for article (PubMed ID: 38302341)
1. SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences.
Wang X; Lu L; Jiang S
Trends Immunol; 2024 Feb; 45(2):81-84. PubMed ID: 38302341
[TBL] [Abstract][Full Text] [Related]
2. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
Parums DV
Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
[TBL] [Abstract][Full Text] [Related]
3. Exploring New COVID-19 Incertitude: JN.1 Variant- JN.1: The Queer Bird Among Omicron Sublineages.
Ray SK; Mukherjee S
Infect Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38939989
[TBL] [Abstract][Full Text] [Related]
4. The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells.
Bugatti A; Filippini F; Messali S; Giovanetti M; Ravelli C; Zani A; Ciccozzi M; Caruso A; Caccuri F
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851546
[TBL] [Abstract][Full Text] [Related]
5. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2.
Hu B; Chan JF; Liu H; Liu Y; Chai Y; Shi J; Shuai H; Hou Y; Huang X; Yuen TT; Yoon C; Zhu T; Zhang J; Li W; Zhang AJ; Zhou J; Yuan S; Zhang BZ; Yuen KY; Chu H
Emerg Microbes Infect; 2022 Dec; 11(1):2275-2287. PubMed ID: 36039901
[TBL] [Abstract][Full Text] [Related]
6. Emergence of a second SARS-CoV-2 variant with a tremendous genetic leap from its ancestors.
Colson P; La Scola B; Beye M; Delerce J; Raoult D; Fantini J
J Med Virol; 2023 Oct; 95(10):e29124. PubMed ID: 37811585
[TBL] [Abstract][Full Text] [Related]
7. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
[TBL] [Abstract][Full Text] [Related]
8. Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.
Basheer A; Zahoor I; Yaqub T
PLoS One; 2023; 18(5):e0281159. PubMed ID: 37224159
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants.
Li Y; Shen Y; Zhang Y; Yan R
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376697
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023.
Jeworowski LM; Mühlemann B; Walper F; Schmidt ML; Jansen J; Krumbholz A; Simon-Lorière E; Jones TC; Corman VM; Drosten C
Euro Surveill; 2024 Jan; 29(2):. PubMed ID: 38214083
[TBL] [Abstract][Full Text] [Related]
11. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and clinical manifestations of patients, including organ transplant patients, during the surge of JN.1: Insights from Saudi Arabia.
Obeid DA; Al-Qahtani AA; Almaghrabi RS; Alahideb BM; Alharbi LA; AlAbdulkareem MA; Almadi TM; Alsanea MS; Althawadi SI; Altamimi SA; Alhamlan FS
J Infect Public Health; 2024 Jul; 17(7):102452. PubMed ID: 38820895
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants.
Roe TL; Brady T; Schuko N; Nguyen A; Beloor J; Guest JD; Aksyuk AA; Tuffy KM; Zhang T; Streicher K; Kelly EJ; Kijak GH
Microbiol Spectr; 2023 Mar; 11(2):e0033323. PubMed ID: 36877050
[TBL] [Abstract][Full Text] [Related]
15. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.
Khan K; Lustig G; Römer C; Reedoy K; Jule Z; Karim F; Ganga Y; Bernstein M; Baig Z; Jackson L; Mahlangu B; Mnguni A; Nzimande A; Stock N; Kekana D; Ntozini B; van Deventer C; Marshall T; Manickchund N; Gosnell BI; Lessells RJ; Karim QA; Abdool Karim SS; Moosa MS; de Oliveira T; von Gottberg A; Wolter N; Neher RA; Sigal A
Nat Commun; 2023 Dec; 14(1):8078. PubMed ID: 38057313
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2: Searching for the Missing Variants.
Caputo E; Mandrich L
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366461
[TBL] [Abstract][Full Text] [Related]
17. The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.
Escalera A; Laporte M; Turner S; Karakus U; Gonzalez-Reiche AS; van de Guchte A; Farrugia K; Khalil Z; van Bakel H; Smith D; García-Sastre A; Aydillo T
Emerg Microbes Infect; 2024 Dec; 13(1):2297553. PubMed ID: 38112266
[TBL] [Abstract][Full Text] [Related]
18. Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75.
Wang Q; Iketani S; Li Z; Guo Y; Yeh AY; Liu M; Yu J; Sheng Z; Huang Y; Liu L; Ho DD
Cell Host Microbe; 2022 Nov; 30(11):1512-1517.e4. PubMed ID: 36108630
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
Beaudoin CA; Petsolari E; Hamaia SW; Hala S; Alofi FS; Pandurangan AP; Blundell TL; Chaitanya Vedithi S; Huang CL; Jackson AP
Biochem Biophys Res Commun; 2023 Jul; 666():61-67. PubMed ID: 37178506
[TBL] [Abstract][Full Text] [Related]
20. Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay.
Aoki A; Adachi H; Mori Y; Ito M; Sato K; Kinoshita M; Kuriki M; Okuda K; Sakakibara T; Okamoto Y; Jinno H
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
